A new trading day began on Monday, with Avidity Biosciences Inc (NASDAQ: RNA) stock price up 7.05% from the previous day of trading, before settling in for the closing price of $41.87. RNA’s price has ranged from $5.04 to $50.78 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 148.90%. Meanwhile, its annual earnings per share averaged 1.80%. With a float of $108.62 million, this company’s outstanding shares have now reached $117.12 million.
Let’s determine the extent of company efficiency that accounts for 253 employees. In terms of profitability, gross margin is 69.4%, operating margin of -2690.64%, and the pretax margin is -2381.82%.
Avidity Biosciences Inc (RNA) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Avidity Biosciences Inc is 7.26%, while institutional ownership is 93.52%. The most recent insider transaction that took place on Oct 21 ’24, was worth 233,168. In this transaction Director of this company sold 5,000 shares at a rate of $46.63, taking the stock ownership to the 14,830 shares. Before that another transaction happened on Oct 21 ’24, when Company’s Director proposed sale 8,323 for $50.45, making the entire transaction worth $419,895.
Avidity Biosciences Inc (RNA) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 1.80% per share during the next fiscal year.
Avidity Biosciences Inc (NASDAQ: RNA) Trading Performance Indicators
Here are Avidity Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 15.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 490.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.95, a number that is poised to hit -0.71 in the next quarter and is forecasted to reach -3.13 in one year’s time.
Technical Analysis of Avidity Biosciences Inc (RNA)
Looking closely at Avidity Biosciences Inc (NASDAQ: RNA), its last 5-days average volume was 0.89 million, which is a drop from its year-to-date volume of 1.32 million. As of the previous 9 days, the stock’s Stochastic %D was 22.79%. Additionally, its Average True Range was 2.28.
During the past 100 days, Avidity Biosciences Inc’s (RNA) raw stochastic average was set at 57.88%, which indicates a significant increase from 38.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.93% in the past 14 days, which was lower than the 57.97% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $44.40, while its 200-day Moving Average is $32.77. However, in the short run, Avidity Biosciences Inc’s stock first resistance to watch stands at $46.56. Second resistance stands at $48.31. The third major resistance level sits at $51.03. If the price goes on to break the first support level at $42.10, it is likely to go to the next support level at $39.38. Now, if the price goes above the second support level, the third support stands at $37.63.
Avidity Biosciences Inc (NASDAQ: RNA) Key Stats
With a market capitalization of 5.20 billion, the company has a total of 109,801K Shares Outstanding. Currently, annual sales are 9,560 K while annual income is -212,220 K. The company’s previous quarter sales were 2,050 K while its latest quarter income was -70,790 K.
